The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut - Wikidata - wikimedia - TriplyDB

The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut

The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut

http://www.wikidata.org/entity/Q34790350

about

Interaction of eosinophils with endothelial cells is modulated by prostaglandin EP4 receptors Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP Castor oil induces laxation and uterus contraction via ricinoleic acid activating prostaglandin EP3 receptors Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease Helminths and harmony E-type prostanoid receptor 4 (EP4) in disease and therapy Integrative approach to analyze biodiversity and anti-inflammatory bioactivity of Wedelia medicinal plants Immune antibodies and helminth products drive CXCR2-dependent macrophage-myofibroblast crosstalk to promote intestinal repair The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4 Inflammatory bowel disease Inflammatory bowel disease RhoA/Rho kinase signaling in the cumulus mediates extracellular matrix assembly.Prostaglandin E2 is required for ultraviolet B-induced skin inflammation via EP2 and EP4 receptors.Prostanoid receptor antagonists: development strategies and therapeutic applications The role of prostaglandin E2 (PGE 2) in toll-like receptor 4 (TLR4)-mediated colitis-associated neoplasia In vivo imaging reveals PKA regulation of ERK activity during neutrophil recruitment to inflamed intestines.Emerging roles of PGE2 receptors in models of neurological disease.Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.EP4 inhibition attenuates the development of diabetic and non-diabetic experimental kidney disease.Dual roles of PGE2-EP4 signaling in mouse experimental autoimmune encephalomyelitis.Antagonizing arachidonic acid-derived eicosanoids reduces inflammatory Th17 and Th1 cell-mediated inflammation and colitis severity.Microsomal prostaglandin E synthase-1 contributes to ischaemic excitotoxicity through prostaglandin E2 EP3 receptors.Emerging roles of prostanoids in T cell-mediated immunity.Crucial role of macrophage selenoproteins in experimental colitis.Insights from advances in research of chemically induced experimental models of human inflammatory bowel disease.Inhibition of EP4 signaling attenuates aortic aneurysm formation Role of Janus kinase 3 in mucosal differentiation and predisposition to colitis Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2-induced allodynia, tactile pain associated with nerve injury.PTGER4 expression-modulating polymorphisms in the 5p13.1 region predispose to Crohn's disease and affect NF-κB and XBP1 binding sites Parturition and recruitment of macrophages in cervix of mice lacking the prostaglandin F receptor Cox-2 deletion in myeloid and endothelial cells, but not in epithelial cells, exacerbates murine colitis.Selective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesis Lymphocytic colitis is associated with increased pro-inflammatory cytokine profile and up regulation of prostaglandin receptor EP4.Crucial role for CD69 in the pathogenesis of dextran sulphate sodium-induced colitis.Prostaglandin E2-prostaglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression.Prostaglandin E2-EP3 axis in fine-tuning excessive skin inflammation by restricting dendritic cell functions.Impact of disrupting adenosine A₃ receptors (A₃⁻/⁻ AR) on colonic motility or progression of colitis in the mouse.

P2860

Q24306707-0825790A-6450-4A5A-B78E-2CB82B913BE9 Q24313175-0EC3FAAF-8305-4587-BB88-471B0A8B0615 Q24562129-CFEACE2B-1064-49A3-A213-1F1A37392327 Q24597553-40F3F2A6-E169-498A-82B4-D440ECBE9F46 Q24626202-05204BC1-CA0C-4418-8B59-CF7BCB1F0D84 Q24685925-F937C818-89C1-4151-91D6-DB65375CCD9F Q26851156-32477BD0-4D0F-4DBE-8D38-16D2719D7515 Q27304925-8738411C-FDC6-47CA-A072-02CFB8156480 Q27320551-5CB06FA7-9DA3-437F-AA67-C42E46C4BB6A Q27322096-06D40725-CF08-4F15-9DFB-44E265BB6896 Q28469186-03218ADA-92F4-47A4-8876-9664DF0A4FA6 Q29615500-41E71EB9-81D4-4802-B0CF-CA5B54905681 Q29616286-0A9670A2-4293-4552-9B6A-C4BE5664EBCA Q30488515-06A0A399-4CF7-4701-90C3-1B2394CF543B Q33262176-C6C1AE43-4C50-47AE-AEF3-AD5C14B48BCE Q33485483-23B5E8DE-D9B9-426C-A3A4-589FD37F2089 Q33634666-DE1A8D08-8957-44E3-A4C4-94C5AACFF653 Q33702929-01C1BE15-11DE-449D-BFD2-A3BBA5A26262 Q33756150-262B638A-BA69-497A-9E30-00B952830AAE Q33770260-5DFD92C1-EA01-4B3E-8BB2-2378E59BAED7 Q33794256-DCD0A183-2C7D-4408-B42B-BF47B2C5B317 Q33982199-A0E81DE1-51BB-4010-979C-36B7B830D378 Q34022356-B360B66D-38BB-4CB6-8075-1CA34C9C74AA Q34112849-A32FBADB-85EB-464A-9CDA-9377E8EA0CFA Q34128367-C288177B-1F1B-4C1D-9438-6F8C071D9A6A Q34218777-F21D184D-2856-4D64-82E0-EB1E0F8C6CF7 Q34233126-6B6DA0F0-A1EA-4013-A307-114757192A7D Q34263414-046EF9D8-5468-45DD-BDA8-F2D23174A02E Q34371948-0401368E-AA2F-447C-B3A8-4A4171FC35B0 Q34420855-B8CE9276-2447-432A-98A1-9BDB6002292E Q34499938-8F10F9E0-495E-4B88-BA55-C68C3581E63A Q34541337-EFCFAB2E-0BE1-436A-B53A-94CB885CDDCD Q34543197-9DA7443B-29C7-4060-8DC1-8DAA47BCD9C3 Q34617230-BDEB6BDD-515B-4263-B82F-5A515AA9F310 Q34662175-C8989AA7-6FD2-4930-9687-902D6899B1C0 Q34685391-104A05AD-E9E1-42CF-B1A7-2A395709E648 Q34778713-2C366F8E-4EA1-44EE-BB36-D47A646A48B7 Q34835869-D05C9817-D137-4FED-B949-D3729FE57AF7 Q34903177-31371599-5861-4386-AC9A-60C040C00E80 Q35048408-8361774B-5686-452B-8A3C-C25BD3D039F7

P2860

The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut

http://www.wikidata.org/entity/Q34790350

description

2002 nî lūn-bûn

@nan

2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

The prostaglandin receptor EP4 ...... CD4 cell activation in the gut

@ast

The prostaglandin receptor EP4 ...... CD4 cell activation in the gut

@en

The prostaglandin receptor EP4 ...... CD4 cell activation in the gut

@nl

type

label

The prostaglandin receptor EP4 ...... CD4 cell activation in the gut

@ast

The prostaglandin receptor EP4 ...... CD4 cell activation in the gut

@en

The prostaglandin receptor EP4 ...... CD4 cell activation in the gut

@nl

prefLabel

The prostaglandin receptor EP4 ...... CD4 cell activation in the gut

@ast

The prostaglandin receptor EP4 ...... CD4 cell activation in the gut

@en

The prostaglandin receptor EP4 ...... CD4 cell activation in the gut

@nl

P1433

Q34790350-E98ABF3C-2B97-452D-A27E-418E956931E4

P1476

Q34790350-2B59169D-C72D-41C8-8594-A9970DDCC093

P2093

Q34790350-12A1EB1D-900F-4743-B205-FA0321C899CB

Q34790350-410F51D8-6ADF-4F61-90CA-E2926E7B0D29

Q34790350-49442AC4-41D1-4BB1-9248-3D16CB10C7F8

Q34790350-7F139992-5CED-4072-B5E2-C2543431CA29

Q34790350-CA7C7DD5-AA0D-490D-8DBB-020AF921AFEA

Q34790350-CF6A5EBF-FF2B-4A1F-974F-1BF747D22888

Q34790350-D13EB599-D29E-41DE-B69C-3400F53A5058

Q34790350-D2999111-626D-406B-B961-B1F0A78288DF

Q34790350-D4AF5837-FCD9-4041-B412-155EE6A04E50

Q34790350-D5657C08-F8F2-413A-A953-0227B0C6A746

P2860

Q34790350-013EBA73-85CD-4C7B-A181-E07548270113

Q34790350-01A1B1A8-D79E-429A-8004-F758B307558E

Q34790350-122635A4-D032-44DD-8F07-13525D9AE232

Q34790350-19D1F31B-00A3-435B-B2CE-AFE5FBCA0BC7

Q34790350-1B985D11-0D2D-4E39-B9F1-86933348DD3F

Q34790350-22630081-29B7-4646-9405-E273264B4E81

Q34790350-22AC0945-3A3B-4AB4-9889-ABD43CE945DF

Q34790350-32CFC0D8-DACB-4562-87CD-E690F3D2190A

Q34790350-3E22DE96-7414-4F78-BED4-EDC3502EDFA1

Q34790350-4173658A-1B4D-4A19-9A7E-58A848E4EA37

P304

Q34790350-8485602B-8C8F-48BD-9042-AE26E1EEA1BB

P31

Q34790350-854CC201-4B40-42D4-8D70-4F80E7DCB77A

P356

Q34790350-36E5A8D1-029A-43BB-9CDC-B30897188BD7

P407

Q34790350-F248AB85-2EDB-44C1-A037-8B210926F0BE

P433

Q34790350-0F208F5C-7F35-473B-9FF6-567671E3C026

P478

Q34790350-C7A6D6FD-8A76-4524-B057-731DB3957C7D

P577

Q34790350-307A3192-7E69-4665-BA8D-34A714C7525C

P698

Q34790350-D635AEEC-F7E1-4020-A4FC-A39581E37DBF

P932

Q34790350-17BFDEA0-028D-436C-876A-41069B5911CF

P356

P1433

Journal of Clinical Investigation

P1476

The prostaglandin receptor EP4 ...... CD4 cell activation in the gut

@en

P2093

Atsushi Ichikawa

http://www.w3.org/2001/XMLSchema#string

Eri Segi

http://www.w3.org/2001/XMLSchema#string

Kazuhito Tsuboi

http://www.w3.org/2001/XMLSchema#string

Kenji Kabashima

http://www.w3.org/2001/XMLSchema#string

Miyako Nagamachi

http://www.w3.org/2001/XMLSchema#string

Shuh Narumiya

http://www.w3.org/2001/XMLSchema#string

Takahiko Murata

http://www.w3.org/2001/XMLSchema#string

Takuya Kobayashi

http://www.w3.org/2001/XMLSchema#string

Tomomi Saji

http://www.w3.org/2001/XMLSchema#string

Toshiyuki Matsuoka

http://www.w3.org/2001/XMLSchema#string

P2860

Abortive expansion of the cumulus and impaired fertility in mice lacking the prostaglandin E receptor subtype EP(2)

Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses

Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3

Prostanoid receptors: structures, properties, and functions

The biology of chemokines and their receptors

Prostanoids in human colonic mucosa: effects of inflammation on PGE(2) receptor expression.

Animal models of mucosal inflammation and their relation to human inflammatory bowel disease.

Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.

Eicosanoids and the large intestine.

Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

P304

883-893

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI0214459

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2002-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11927615

http://www.w3.org/2001/XMLSchema#string

P932

150928

http://www.w3.org/2001/XMLSchema#string